Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortizatization of Intangibles Asset Writedowns and Impairment Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Cash from Restructuring Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Receivables Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation and Depletion Dividends Paid - Common Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Income Non-cash Items Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Altimmune (ALT) Amortization of Goodwill (2017 - 2018)

Historic Amortization of Goodwill for Altimmune (ALT) over the last 2 years, with Q1 2018 value amounting to $490676.0.

Altimmune's Amortization of Goodwill changed N/A to $490676.0 in Q1 2018 from the same period last year, while for Sep 2018 it was $9.8 million, marking a year-over-year change of. This contributed to the annual value of $35.9 million for FY2017, which is N/A changed from last year.
As of Q1 2018, Altimmune's Amortization of Goodwill stood at $490676.0.
Altimmune's 5-year Amortization of Goodwill high stood at $26.6 million for Q3 2017, and its period low was $490676.0 during Q1 2018.